Screener
Regenxbio RGNX Royalty Monetization Liabilities Current
Royalty Monetization Liabilities Current at other companies
Other financials
Where this comes from
Reported directly by Regenxbio in its filing.
Tagged under the XBRL concept rgnx:RoyaltyMonetizationLiabilitiesCurrent.
The source filing: Regenxbio’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 7:15 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-336725
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Accrued expenses and other current liabilities | 23,073 | 38,390 |
| Deferred revenue | 9,882 | 10,452 |
| Operating lease liabilities | 7,355 | 8,286 |
| Royalty monetization liabilities | 26,765 | 39,609 |
| Total current liabilities | 82,621 | 118,095 |
| Deferred revenue | 15,404 | 18,943 |
| Operating lease liabilities | 61,596 | 65,215 |
| Royalty monetization liabilities | 154,746 | 147,408 |
Item 1. Financial Statements.
FAQ
- What is Regenxbio's royalty monetization liabilities current?
- Regenxbio (RGNX) reported royalty monetization liabilities current of $26.77M in Q2 2026.
- How has Regenxbio's royalty monetization liabilities current changed year-over-year?
- Regenxbio's royalty monetization liabilities current decreased by 33.6% year-over-year, from $40.3M to $26.77M.
- What does royalty monetization liabilities current mean?
- Royalty Monetization Liabilities Current as reported by REGENXBIO Inc..
Ask your AI about Regenxbio's royalty monetization liabilities current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude